
Living with Follicular atrophoderma and basal cell epitheliomata
A rare inherited skin condition (Bazex-Dupre-Christol syndrome) with a tendency to develop basal cell skin cancers early in life.
Understanding Follicular atrophoderma and basal cell epitheliomata
People with it are prone to developing basal cell carcinomas, a common type of skin cancer, at an early age.
Signs & symptoms
GARD lists these among the less common findings, and we don't have enough information about how common they are:
- Early basal cell skin cancers
- Trichoepithelioma (hair-follicle skin growth)
- Eczema
- Atopic dermatitis
- Acne inversa
Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.
Diagnosis
- 1Talk with your doctor
Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.
- 2See a specialist
Specialists who may be involved include cancer specialists, genetic specialists and skin, hair, and nail specialists.
- 3Ask which tests can help
Your care team will decide which exams and tests can confirm the diagnosis.
Care & treatment
- Care team
- Cancer specialists (oncologists); Genetic specialists (geneticists); Skin, hair, and nail specialists (dermatologists)
- Expert care
- Ask about multidisciplinary care centers for rare conditions
- Treatment
- GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
- Research
- Clinical trials and observational studies may be options. See the research section below.
General information, not medical advice. Your care team makes the decisions.
Everyday life
Living with a rare condition is easier with support.
- Connect with Children's Skin Disease Foundation
- Keep notes on symptoms, changes and questions for appointments
- Ask about patient registries that help research
- Look into financial aid and travel resources for care visits
Quick facts
Changes in genes cause it. It is X-linked, which means the gene is on the X chromosome. GARD doesn't name the gene.
Also known as: acrokeratosis of bazex; acrokeratosis paraneoplastica; acrokeratosis paraneoplastica of bazex; bazex syndrome; bazex syndrome, x-linked dominant; bazex-dupre-christol syndrome
Patient organizations
- Children's Skin Disease FoundationSkin diseases · United States
Broader rare-disease groups
- Global GenesRare Diseases · United States
- National Organization for Rare DisordersRare Diseases · United States
- Genetic AllianceRare Diseases · United States
- RARE FoundationRare Diseases · United States
You are more than your diagnosis
Perspectives from people navigating life with Follicular atrophoderma and basal cell epitheliomata.
Explore research for Follicular atrophoderma and basal cell epitheliomata
Explore actively recruiting Follicular atrophoderma and basal cell epitheliomata studies with HealthSpark.
Find actively recruiting studies for Follicular atrophoderma and basal cell epitheliomata with HealthSpark. Share your city to explore research near you.
- Recruiting studies from ClinicalTrials.gov
- Share your city to look for research near you
- Eligibility is confirmed by the study team
Powered by HealthSpark, our AI chat helper
I can help you find recruiting Follicular atrophoderma and basal cell epitheliomata studies. Enter a ZIP code, address or city below and I'll look within 50 miles.
Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.
Get Signals for Follicular atrophoderma and basal cell epitheliomata
Stay in the loop with community stories and updates from medical researchers.
Create a living journal that talks back
HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Follicular atrophoderma and basal cell epitheliomata experiences more deeply and prepare for better conversations with your doctors and care team.
Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.



